How ChatGPT Can–and Can't–Help Your Job Search 3/9/2023
QurAlis’ Biomarker-Driven Approach Attracts $88M in Series B 3/9/2023
Lilly’s Alzheimer’s Struggles Continue as Preclinical Disease Asset Fails Phase III 3/9/2023
Closing the Opportunity Gap: How Inceptor Bio Supports Women Leaders 3/9/2023
Boehringer Ingelheim to Mine Ginkgo’s Molecules in $406M Undruggable Targets ... 5/8/2023
BioNTech Looks to Expand into Other Markets as COVID-19 Revenues Dwindle 5/8/2023
BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model 5/8/2023
Biopharma Bets Big on Antibody-Drug Conjugates 5/8/2023
Opinion: Hope on the Horizon for Sjogren’s Syndrome 5/8/2023
FDA Action Alert: Sarepta, Protalix, Otsuka/Lundbeck and More 5/8/2023
FDA Guidance May Bolster Confidence in Decentralized Clinical Trials 5/8/2023
In Tough Market, CODA Quietly Shuts Doors 3/8/2023
BioMarin Answers BridgeBio's Challenge with sNDA for Achondroplasia 3/8/2023
FDA Accepts Mesoblast’s Ryoncil Resubmission for Pediatric GVHD 3/8/2023
Co-working could Drive Innovation, Distribution of Talent Across U.S. 3/8/2023
The Decade of RNA Delivery – Beyond the Liver 3/8/2023
Makena Saga Concludes as FDA Withdraws Approval for Only Preterm Birth Drug on Market 4/7/2023
Novavax Presents COVID-19 Booster and Flu Combo Vaccine Studies 4/7/2023
World Vaccine Congress Panel Highlights Exigency of AMR Global Health Crisis 4/7/2023
Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail 4/7/2023